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Phosphorcscencc and optically detected magnetic resonance (ODMR) have been used to characterize two synthetic peptides. ul81-198 and 
a185-196. of the major binding determinant of the a-acetylcholine r ceptor (AChR) of Torpedo culijbrrticu and its interaction with rr~bungarotoxin 
(6gTX) using Trp as an intrinsic probe. BgTX conformational change% are suggested upon complexation with the peptides. Methylmercu~ 
modified peptides how conformational heterogeneity which brings some of the modified Cys residues into proximity of peptide Trp(s). These 
modified pcptidcs, when bound to B&IX. undergo structural changes which remove the tagged Cys from its close contact with the Trp residue(s) 
of the peptide. 
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1. INTRODUCTION 
The nicotinic acetylcholine receptor (AChR) is a pcn- 
tameric transmembrane protein assembled from four 
structurally related subunits, a&y& It functions as a 
ligand-gated channel protein mediating signalling in 
vertebrate skeletal muscle. The a-subunit is largely re- 
sponsible for specifying the cholinergic ligand binding 
sites which number two per receptor. A segment, a173- 
204, of the a-subunit of the AChR from electroplaque 
of Torpedo culifornica has been shown to contain the 
main binding determinant [l], Small segments within 
this region, a181-198 and a185-196, display micro- 
molar affinity towards the cholinergic antagonist a- 
bungarotoxin (BgTX) [23. 
In this work we describe the use of low temperature 
phosphorescence and optically detected magnetic re- 
sonance (ODMR) to investigate the environment of Trp 
residues present in two a-subunit synthetic peptides 
when the peptides are either unbound or bound to 
E&TX. Two peptides are investigated, one that is 18, 
and the other 12 residues long. The lSmer, 
Y’8’RGWKHWVYYTCCPDTPY1’8, contains two Trp 
residues, Trp”’ and Trp’“, and the 12mcr, 
K’e5HWVYYTCCPDT’96, contains only Trp’“‘. An 
elegant model has been proposed previously which 
suggests that a direct hydrophobic interaction occurs 
between an aromatic residue of the toxin and a Trp 
residue of the AChR peptide upon complexation [3,4]. 
A primary motivation for undertaking this investigation 
was to test the validity of this model. A further induce- 
ment is the presence of the highly conserved Cys 
residues at adjacent positions 192 and 193. These 
cysteines form a highly strained and easily reduced vi- 
cinal disullide bond in the intact AChR [5,6]. The pres- 
ence of cysteine is not, however, a requirement for 
BgTX binding [I], although several studies using syn- 
thetic peptides or the intact AChR in which Cys’“’ and 
Cys’“3 are chemically modified or substituted by other 
amino acids have shown a decreased BgTX affinity [S- 
lo]. The fortuitous placement of Cys at the binding site 
allows for the attachment of a thiol-specific heavy-atom 
probe. If a Trp residue is located in the immediate prox- 
imity of a heavy-atom-modified peptide thiol, when the 
peptide is either unbound or in a complex with BgTX, 
then a Trp heavy-atom effect (MAE) may be used to 
further elucidate toxin-peptide interactions. 
2. EXPERIMENTAL 
*Prwnr orl,lress: Institute of Gerontology, The University of Mich- 
igan, 300 North Ingells, Ann Arbor, MI 48109. USA 
Corresporrhxc adhw: A.M. Maki, Department of Chemistry, Uni- 
versity of California, Davis, CA 95616, USA 
The unblocked synthetic peptides, 18mer and 12mer. were syn- 
thesized at the Protein Chemistry Facility, Yale University School of 
Medicine, New Haven, CT. Greater than 90% of the l?mcrand ltmer 
peptide thiols were in the reduced state. Solutions were prepared in 
triply distilled water and subsequently adjusted to pH 8. BgTTX, also 
dissolved in water, was a generous gitt from Professor Mark 
MacNamee of the Department of Biochemistry and Biophysics, Uni- 
versity of California, Davis, CA. One to one molar ratio peptidc-toxin 
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complexes were prepared and incubated for 15 min at room tcmpera- 
pure. CI-i,l-@modified pcptidcs were prepared by addition of’ can- 
centrated CH,Hgl dissolved in cthylcnc glycol to peptide (a 3:l molar 
ratio was used) followed by incubation at 37°C for ca. one hour. 
Binding of the modified peptidcs to the toxin followed the procedure 
described above. All samples were adjusted to 30% ethylene ylycol 
(v/v) prior to spectroscopic measurements. 
The procedures for obtaining phosphorescence spcctm, triplet slate 
lifetimes and ODMR spectra have been described previously [I I]. All 
data presented here were obtained with sample excitation centered 
around 300 nm with 16 nm bandpass. 
3. RESULTS AND DISCUSSION 
3.1. AChR model peptides 
The phosphorescence of both the l2mer and the 
18mer are typical of samples containing both Trp and 
Tyr in that only the well-resolved emission of the former 
is observed. As shown in Table I the 1 Smer phosphores- 
cence is shifted by ca. 1.4 nm to lower energies relative 
to the emission of the 12mer. This may be due to the 
added contribution of Trpis4 to the emission or to a 
more polarizable nvironment for either or both of the 
1Smer’s Trps. The major lifetime component (ca. 6.7 s) 
of both peptides (Table I) is assigned to Trp. The minor 
component may be due to Tyr or it may arise from a 
Trp in close proximity to an intrapeptide disulfide, 
CyP-CyP, which is present in small amounts 
(~10%) in our samples. Trp-disulfidc interactions are 
known to reduce phosphorescence lifetimes (see discus- 
sion below). 
The zero-field ODMR peak frequencies of the 12mer 
(Fig. IA) and 18mer are virtually identical (Table I). 
The frequencies of the slow passage ODMR transitions 
can be empirically correlated with triplet state energy 
and also with some success to the degree of solvent 
exposure of Trp [12]. In the present case, the degree of 
Trp solvent exposure in the small peptides is similar to 
that observed for the solvent exposed Trp of the 
hormones glucagon or somatostatin [ 131. Another indi- 
cator of site homogeneity is reflected in the linewidth of 
the D-E signal [12]. The 18mer D-E linewidth of 150 
MHz is significantly less than the observed linewidth of 
220 MHz for this transition in the 12mer and may be 
interpreted to be a consequence ofa smaller distribution 
of Trp-peptide interactions in this significantly larger 
model peptide. Its red-shifted emission is consistent 
with a more polarizable nvironment. 
3.2. Model pcptide cotnpkxes with BgTX 
When the model peptides are bound to BgTX the 
triplet state energies, lifetimes and ODMR peak fre- 
quencies are affected noticeably in comparison with the 
unbound peptides. The D-E transition linewidth of the 
unbound 12mer, 220 MHz, decreases considerably to 
150 MHz upon complexation with BgTX (Fig. 10 
Similar decreases in ODMR linewidths were observed 
for ISmer binding to BgTX (Table I). This suggests a
more ordered environment for Trp(s), as expected, 
upon complex formation. 
In previous work [11,14] we have demonstrated that 
Trp?’ of BgTX is quenched in the triplet state by the 
presence of the disulfide bridge between Cys?’ and 
Cys”. Triplet state Trp-disultide interactions are 
known to be extremely short-range in nature [IS] (an 
effective Bohr radius of L = 0.8 A has been determined). 
For BgTX the triplet quenching was manifested by the 
observation of a low phosphorescence to fluorescentie 
quantum yield ratio (0.02 compared with 0.28 for Trp 
in frozen solutions), an anomalously shortened triplet 
lifetime and the presence of an unusual negative polarity 
D-E signal upon excitation-at 300 nm (Fig. I Et). The 
absence of a shortened Trp lifetime (Table I) for the 
peptide-BgTX complexes uggests that BgTX under- 
goes a conformational change upon peptide binding 
resulting in an increase of the disulfide-tryptophan dis- 
tance, thereby reducing the quenching of Trp?“. Similar 
arguments were used previously to explain phosphores- 
Table I 
Triplet state propcrdcs of AChR model peptides and their complexes with a-bungarotoxin 
Sample* &J”” Lifetimes D-E” 2E” 
(nm) (5) (GHr-) (GHz) 
IZmer 409.9 (15%) 2.43 (85%) 6.79 (+) 1.74 (220) (+) 2.51 (300) 
1 Smrr 411.3 (8%) 2.78 (92%) 6066 (+) 1,71 (150) (“) 2.55 (270) 
BSTXc 412.2 (45%) 1.1 (55%) 5.5 (-) 168 (IGO) (+) 2.51 (170) 
12mer:BgTX 410.1 (20%) 2.63 (SO%) 6.5 I (“) 1.73 (155) (I-) 2.59 (2GO) 
18mer:BgTX 410.9 (15%) 2.50 (85%) 6 20 (+) 1.67 (130) (“) 2.56 (250) 
‘Snmplcs were dissolved in water and contained 30% (v/v) ethylene Slycol. 
bAssigncd O,O-band of phosphorescence at which all kinetic and ODMR measurements were made using excitation centered at 300 nm with 16 
nm bandpass. 
‘Lifetimes were extracted from the observed ecays at 77 K using a least-squares technique. The percentage of the total emission is in parentheses 
Immedh1dy preceding :!I: extracted !if.etimc, 
“The parentheses preceding the ODMR peak frequencies indicate whether the observed transition is an increase, (+), or decrease, (-), in 
phosphorctscencc i tensity with respect o the total stendystate omission. The parentheses following the .ODMR peak frequencies contain the 
observed linewidth of the transition in MHz. Observations were made at I .2 K. 
cData from [I 11. 
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cence lifetime changes of disulfide-perturbed Trp 
residues of hen egg white lysozyme and the Fab’ frag- 
ment of the anti-galactan antibody 5539 upon ligand 
binding [16]. This explanation is in line with the qualita- 
tive observation of an overall AChR peptide-toxin 
complex phosphorescence intensity which is larger than 
the sum of the intensities obtained for the isolated toxin 
and peptide. This effect on phosphorescence quantum 
yield parallels the fluorescence enhancement observed 
in solution upon binding the weakly emitting BgTX (& 
= 0.036) to the 12mer and the 18mer [2]. Since disulfides 
are very efficient singlet state quenchers, adisplacement 
of the Trpz8 residue of BgTX with respect o the Cys”- 
CY$~ disulfide may account in part for changes in both 
room temperature fluorescence and the low tempera- 
ture phosphorescence upon binding. BgTX conforma- 
tional changes have been suggested previously by NMR 
studies of its binding to receptor prototopes [l’i]. Flexi- 
bility in the end of the p-pleated structure which in- 
cludes Trp”” has been postulated to account for dif- 
ferences in BgTX crystal and solution structures [18]. 
Low and Corfield have proposed a dynamic model of 
toxin-receptor binding [3,4] in which a receptor Trp fits 
tightly into a toxin hydrophobic ‘Trp’ cleft. According 
to this model, shifts in neurotoxin residues would make 
possible direct hydrophobic binding interactions be- 
tween the receptor Trp and one of two toxin aromatic 
residues, Trp’” or Tyr?’ [3]. Model studies suggest that 
of the two Trps in the main binding determinant of the 
a-subunit, Trp18’ is the more stereochemically probable 
residue to be entrapped by the toxin [4]. One expects 
that this type of a stacking interaction would be ac- 
companied by a decrease in the D ZFS parameter result- 
ing from triplet wavefunction expansion ormal to the 
Trp aromatic plane [ 121. For example, the hydrophobic 
interactions of Lys-Trp-Lys with polydeoxythymidic 
and polyriboadenylic acids result in reductions in D of 
30 and 36 MHz, respectively, for the Trp residue [19,201. 
It was suggested above that the Trp?’ emission of BgTX 
is most probably unmasked upon peptide binding so 
that its contribution to the spectral properties of the 
complex cannot be ignored. We will analyze the phos- 
phorescence and ODMR of the peptide-BgTX com- 
plexes by considering the contribution of each Trp se- 
parately. Ignoring for the moment the contribution 
from Trp” of the toxin, changes in emission of the 
12mer Trp”‘, in the complex with &TX, result in a 
slight increase in D of 30 MHz. If we assume that there 
is a hydrophobic interaction between Trp18’ and Tyr24 
we expect o observe a reduction in the D ZFS parame- 
ter. If on the other hand, we ignore any contribution 
from Trp’“’ of the 12mer, we find that BgTX Trp’” 
shows an increase in D of 90 MHz upon 12mer binding. 
Both interpretations appear to be inctir&ttint with ths 
direct hydrophobic interaction of Trpla7 of the lamer 
and either BgTX Trp2’ or Tyti4. The 18mer shows a 
decrease in D of 30 MHz, a small decrease in ODMR 
Fig. 
1.3’ 1.7 26 2.5 2.9 3.3 3.7 4.1 4s 4.9 3 
Frequency ItHz) 
I, Slow passage ODMR spectrum of (A) 12mer. (B) t3gTX. (C) 
llmcr complexed with BgTX. and (D) I2mcr complcxed with 
CH,Hg’. Samplce were dissolved in a water:ethylcncglycol, 30% WV), 
solution, (A). (B) and (C) were recordLxJ at I.2 K with a sweep mlc 
al’ 67 MHz&. (D) was obtained at 4.2 K with a sweep rate ol’ 5 
GHzts-‘, conditions under which the signals of (A), (I1) and (C) were 
not observed. bch sample was exit&l at 300 nm using 16 nm 
bandpass. 
linewidth, but a slight blue-shift in phosphorescence 
upon binding BgTX. It is thus possible that Trplti af the 
18mer undergoes a hydrophobic interaction with a 
toxin aromatic residue. It may also be possible to inter- 
pret the decrease in D as a reflection of the greater than 
four-fold higher affinity that BgTX displays for the 
18mer elative to its affmity towards the 12mer [2] if we 
assume that binding affinity is enhanced by increased 
hydrophobic interaction upon complex formation. 
Recent NMR evidence supports the lack of direct stack- 
ing interactions between toxin and peptide aromatic 
residues [21], in agreement with the interpretation above 
of phosphorescence and ODMR observations. 
Table II 
Triplet state kinetics of CH,Hg-modified AChR model pepddes and 
their complexes with a-bungarotoxin 
Sample’ &0” Lifctimcs’ 
(nm) (5) 
IZmcr:CH,Hg 4lG.l (15%) 0.06 (30%) 0.60 (55%) 4.36 
I8mer:CH,Hg 416.1 (22%) 0.18 (31%) 1.65 (47%) 5.57 
lZmer:CM,Hg:BgTX 4 I I .2 (10%) I .42 (90%) 6.56 
I 8mcr:CHJHg:BgTX 41 I .3 (12%) 1.90 (88%) 6.00 
Isbf See footnotes to Table 1 
89 
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3.3. CH3Hg-rttodiJied peprides artd their cotttplexes with 
&TX 
CHJHgI is a thiol-specific reagent [22,23] and under 
the experimental conditions used here, it forms a com- 
plex with the free Cys at positions 192 and 193. The 
observation i  the CH3Hg-modified peptides of reduced 
lifetimes, significant red-shifted phosphorescence 
(Table II) and ODMR spectra (Fig. 1 D) obtained under 
conditions in which unperturbed Trp does not show, 
ODMR (rapid microwave sweep rates and a tempera- 
ture of 4.2 K compared with slow sweep rates and a 
temperature of 1 .2 K normally required for un- 
perturbed Trp) are a clear indication of an external 
HAE on peptide Trp(s), This is a short-range interac- 
tion with a reciprocal sixth power dependence on heavy- 
atom-perturber to chromophore distance, indicating 
that Trp’“’ of the 12mer is in close proximity to 
modified Cyslg’ and/or modified C~S’~~. The spread in 
the observed lifetimes of the single tryptophan-contain- 
ing 12mer (Table 11) and especially the significant con- 
tribution of a 4-5 s lifetime component suggest hat 
there may be a distribution of conformers present in the 
CH,Hg-modified peptide. The proportion of the long- 
lived component in the total decay is greater than one 
would expect if the CH3Hg-unmodified thiols, i.e. those 
involved in vicinal disulfide linkages (comprising 
<lo%), are taken into account. Similar arguments ug- 
gest that conformational disorder is present in the 
CH3Hg-modified 18mer (Table II). On the other hand, 
when the CH3Hg-modified peptides are bound to 
BgTX, the HAE on Trp is no longer present. The life- 
times and phosphorescence for 12rner:CH3Hg:BgTX 
and for 18mer:CH3Hg:BgTX (Table II) are similar to 
those observed for the free, unmodified peptides (Table 
I). The disappearance of the HAE in the peptide com- 
plexes indicates implicitly that the modified peptides 
bind to BgTX. Furthermore, a structural change must 
occur upon binding in both 12mer and 1Smer AChR 
peptides that removes the peptide Trp(s) from the neigh- 
borhood of the CH,Hg-tagged peptide cysteines. Con- 
formational change of the AChR [24] and also of model 
peptides [17] have been observed previously upon neu- 
rotoxin binding. The absence of a MAE in the complex 
also implies that neither of the heavy-atom modified 
peptide thiol groups are placed in the immediate prox- 
imity of Trp” of BgTX. 
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